CS Paper Radar

Exploring the Latent Structure of AMD Severity Using Retinal Foundation Models

Niccolò Fineschi, Jovana Panic, Atsushi Watanabe, Hideaki Hayashi, Kazuya Nishimura, Yuki Maeno, Samanta Rosati, Gabriella Balestra, Kohji Nishida, Hajime Nagahara

eess.IV cs.CV ·submitted 2026-10-09 13:50 UTC · v1
published

Abstract

Retinal foundation models have demonstrated strong performance across a wide range of ophthalmic tasks, yet relatively little is known about how disease-related information is represented within their learned embeddings and whether this distribution influences downstream prediction performance. In this work, we use Age-related Macular Degeneration (AMD) as a case study to investigate how disease severity is represented within the embedding space of RET-CLIP, a retinal vision-language foundation model, using bilateral fundus images from the AREDS dataset, benchmarked against non-retinal encoders. We first characterize the distribution of AMD severity within the learned representation space and then evaluate how this structure influences classification performance across three clinically relevant task formulations of increasing granularity. Finally, we analyze the most influential latent dimensions combining feature attribution, statistical phenotype association, and qualitative image analyses. Our results show that RET-CLIP represents AMD severity as a continuous spectrum rather than a set of discrete categories, with healthy and advanced disease stages exhibiting clearer separation than intermediate ones. This organization was reflected in downstream performance, which decreased from a balanced accuracy of 0.844 and 0.814 for binary AMD and Late-AMD detection respectively to 0.446 for six-class grading. Furthermore, the most influential latent dimensions were statistically associated to distinct retinal phenotypes, including drusen accumulation, pigmentary alterations, and advanced retinal lesions. These findings suggest that the structure of retinal foundation-model representations influences the difficulty of clinically relevant prediction tasks and demonstrate the potential of representation-level analysis for understanding disease organization and improving interpretability.

Comment
7 pages, 5 figures. Accepted for publication at IEEE EMBS BHI 2026

Closest papers

Nearest neighbours by meaning across the whole index.

A Disease-specific Retinal Aging Biomarker for Predicting Progression to Late Age-related Macular Degeneration

cs.CV ·2026-11-12 ·Hexin Dong, Benjamin Hou, Puzhen Wu, Mingquan Lin, Emily Y. Chew +2 more
similarity 0.75
Abstract · 41 pages, 13 figures (including supplementary material)

Age-related macular degeneration (AMD) is a leading cause of irreversible vision loss in older adults. While chronological age is a primary risk factor, it inadequately reflects individual variations in retinal aging, limiting effective AMD risk stratification and timely intervention. Here, we propose and validate fundus-based AMD age (FAA), which quantifies disease-specific retinal aging in AMD and captures accelerated AMD-related retinal aging, thereby improving prognostic precision over chronological age. Trained on 36,782 images from 2,192 participants in the Age-Related Eye Disease Study (AREDS) dataset and validated across AREDS and AREDS2 cohorts, our model demonstrates significant improvements over traditional chronological age-based approaches. Specifically, integrating the proposed FAA into Cox proportional-hazards models significantly enhances prediction performance. FAA improved the C-index from 0.836 to 0.888 and reduced the 5-year Brier score from 0.050 to 0.046 in AREDS, with consistent gains observed in AREDS2 (C-index 0.715 to 0.756; 2-year Brier 0.078 to 0.076). FAA showed improved prognostic performance across the two datasets and under different phenotype definitions (reading center-defined vs. specialist-defined grading), supporting its potential utility for AMD risk stratification. These findings highlight the advantage of incorporating FAA into AMD risk prediction frameworks, supporting further evaluation of FAA for AMD risk stratification.

0.21

Self-supervised Pre-training Helps Retinal Disease Progression Modelling Most When Data Is Scarce

cs.CV ·2026-09-11 ·Ifeoma Veronica Nwabufo, Julius Gervelmeyer, Sarah Müller, Philipp Berens
similarity 0.75
Abstract

Modelling how a disease progresses over time requires longitudinal imaging cohorts, which are scarce and small, whereas cross-sectional data -- one image per participant -- is abundant. Self-supervised pre-training on such data offers a way to bridge this gap, but it is unclear which strategy best supports progression modelling, or how that answer depends on the amount of labelled longitudinal data. We study this for age-related macular degeneration (AMD), pre-training encoders on the large cross-sectional NAKO cohort and predicting time to late AMD on the longitudinal AREDS dataset. We compare in-house self-supervised encoders against a general-purpose (DINOv2) and a domain-specific (RETFound) foundation model, across contrastive, masked-autoencoding, and self-distillation objectives, under frozen and fine-tuned protocols, and across labelled training sets from 100 to 32,250 examples. Which model performs best depends on how the encoder is used. When the encoder is frozen and labels are few -- the regime typical of longitudinal cohorts -- pre-trained representations reach clinically reasonable discrimination from a few hundred labelled samples, while models trained from scratch do not; this advantage fades under fine-tuning. Transfer is governed by the self-supervision objective rather than corpus scale or domain match, so that an encoder pre-trained on a modest cross-sectional cohort matches or exceeds a far larger in-domain foundation model. Together, these results offer a practical recipe for building progression models where longitudinal data is scarce: a frozen self-supervised encoder with a lightweight survival head.

0.15

FOCUS: Benchmarking Retinal Model Generalization from Foundation Vision Encoders to Multimodal LLMs

cs.CV cs.AI ·2026-09-27 ·David Restrepo, Chenwei Wu, Luis Filipe Nakayama, Miguel L. Martins, Stergios Christodoulidis +2 more
top venuebenchmarkdatasetcode/data similarity 0.72
Abstract · Accepted at NeurIPS 2026, Evaluations & Datasets Track. Interactive benchmark dashboard: https://huggingface.co/spaces/dsrestrepo/FOCUS-Reti…

Progress in AI-based retinal image analysis has accelerated with the adoption of foundation models, yet evaluating their real-world reliability remains challenging. Performance reported on a single dataset does not capture how models behave under dataset shift, across clinical definitions, or for different patient subgroups. This limitation is particularly critical in medical imaging, where robustness, calibration, and fairness are essential for safe deployment. We introduce FOCUS (Foundation Ophthalmic Cross-Dataset Understanding under Shift), a cross-dataset benchmark evaluating retinal fundus models across vision-only encoder models (VM), vision-language dual-encoder models (VLM), and multimodal large language models (MLLM). FOCUS harmonizes binary diabetic retinopathy, referable diabetic retinopathy, and glaucomatous optic neuropathy tasks across ten public datasets spanning diverse geographies, acquisition conditions, and label protocols. The benchmark evaluates models through a unified analysis layer that measures ranking performance, calibration, subgroup disparities, and image-quality robustness. We present a large-scale evaluation covering 532 base configurations and 228 MLLM configurations adapted via LoRA fine-tuning. Results show no model family consistently dominates across tasks and datasets: general VM encoders achieve the strongest average ranking performance, medical MLLMs are competitive but variable, and dual-encoder VLMs benefit substantially from lightweight adaptation. Fine-tuning improves in-domain performance but exhibits heterogeneous transfer to external datasets, particularly in calibration. FOCUS provides a practical framework and public benchmark to assess generalization, reliability, and robustness beyond single-dataset leaderboards.

0.52

CAMEL: Cross-Architecture Masked Embedding Learning for Ultra-Lightweight Retinal Foundation Models

cs.LG cs.AIcs.CV ·2026-10-29 ·Andre Guarnier De Mitri, Giovani Decico Lucafo, Miller Matheus Lima Anacleto Rocha, Diego Furtado Silva
similarity 0.71
Abstract · 8 pages, 6 figures, pre-print

Recent progress in deep learning has substantially advanced automated grading of ophthalmologic pathologies, supported by large annotated datasets and improved representation learning. However, a significant gap remains between state-of-the-art performance and clinical scalability. In particular, foundation models have reshaped image-based medical screening and diagnosis. These large-scale architectures trained on extensive datasets learn rich, generalizable feature representations that can be adapted to a wide range of downstream tasks. In ophthalmology, RETFound, one of the most relevant foundation models for retinal images, performs strongly across classification, segmentation, and risk prediction tasks. Despite their effectiveness, foundation models are often computationally prohibitive, hindering their deployment in real-world clinical environments where hardware constraints and latency are critical. To bridge this gap, we introduce CAMEL (Cross-Architecture Masked Embedding Learning), a novel cross-architecture distillation framework that uses an asymmetric masking strategy during embedding learning to effectively transfer knowledge from massive teacher foundation models to compact, lightweight student models. Our experimental evaluation across four datasets shows that CAMEL preserves accuracy while drastically reducing computational complexity, enabling lightweight yet highly accurate models suitable for resource-limited clinical settings.

0.21

Evaluation of Clinically Steerable Retinal Image Generation from Foundation Model Latent Spaces

cs.CV ·2026-08-13 ·Zuzanna A. Wakefield-Skórniewska, Bartłomiej W. Papież
published similarity 0.69
Abstract · MICCAI 2026 Workshop SASHIMI Submission

Medical foundation models learn latent representations of clinically meaningful phenotypes, yet their ability to support controllable image generation remains largely unexplored. We evaluate four retinal foundation models within the representation tokenizer framework and examine whether demographic and clinical information encoded in latent representations from foundation models is preserved during synthetic image generation. We show that generated representations and images faithfully inherit phenotype information when evaluated within their originating foundation models, consistently outperforming conventional latent diffusion on multiple downstream prediction tasks. However, these gains largely disappear when evaluated using classifiers trained on real images, revealing a previously uncharacterised synthetic-to-real representation gap. These findings demonstrate that foundation-model latent spaces provide a powerful substrate for controllable retinal synthesis while highlighting the need to better align synthetic representations with real-image distributions.

0.17

Beyond Accuracy: Benchmarking Uncertainty Quantification in Retinal Disease Screening

eess.IV ·2026-11-17 ·Mahvash Jebeli, Mohammad Eslami, Nazlee Zebardast, Lucia Sobrin, Tobias Elze
benchmarkdataset similarity 0.66
Abstract

Reliable uncertainty quantification (UQ) is essential for evaluating retinal AI systems beyond classification accuracy, yet it remains unclear whether existing UQ strategies generalize across diseases, model architectures, and reliability criteria. We introduce a large-scale, multi-disease benchmark comprising over $242,000$ fundus photographs from $32$ datasets covering diabetic retinopathy, age-related macular degeneration, and glaucoma. We evaluate six representative UQ strategies across three Vision Transformer configurations, assessing discrimination, probabilistic calibration, selective prediction, and conformal prediction-set coverage. Our findings reveal no universally superior model or UQ strategy: methods that improve reliability in one disease or architecture may underperform in another, while improvements in discrimination, calibration, and selective prediction do not necessarily align. Notably, computationally intensive methods do not consistently outperform simple confidence scores, and domain-specific foundation models and calibration-oriented loss functions do not guarantee greater reliability. In contrast, conformal prediction provides a complementary framework for achieving near-nominal marginal prediction-set coverage across diverse settings, subject to its statistical assumptions. These findings challenge universal UQ recommendations and highlight the need for disease-specific, model-specific, and multidimensional reliability evaluation before clinical deployment. We release standardized dataset splits, trained checkpoints, evaluation code, and an interactive research demonstration to support reproducible benchmarking.

0.06

Interpretable Context-Aware Multi-Label Retinal Classification with Dual-Hub Heterogeneous Graph Neural Network

cs.CV cs.LG ·2026-11-06 ·Proshanto Chanda, Munib Mesinovic, Tingting Zhu, Abhirup Banerjee
code/data similarity 0.66
Abstract

Multi-label retinal screening requires capturing co-occurring pathologies and clinical context, yet standard multimodal fusion remains opaque. We propose a dual-hub heterogeneous graph neural network (GNN) that couples spatial fundus features and structured clinical covariates through cross-modal message passing while providing inherent interpretability. Rather than relying on post-hoc saliency approximations, our architecture exposes multi-level decision pathways during forward aggregation: spatially biased self-attention captures lesion-level patch interactions, while modality-specific graph attention coefficients explicitly quantify the contribution of visual regions and clinical risk factors to each disease node. Evaluated on the BRSET dataset (16,266 photographs from 8,524 patients), the proposed model achieves 76.1% Macro-AUPRC across seven conditions, matching or exceeding image-only (75.9%) and ResNet-50+MLP fusion (75.9%) baselines, with largest contextual gains in macular edema (+3.5 percentage points, pp) and diabetic retinopathy (+2.1 pp). Codebase is available at: https://github.com/proshanto-c/ca-mlc-refactor.

0.31

Automated 2D and 3D Segmentation of AMD and DME Lesions in OCT

cs.CV ·2026-08-27 ·Lucia Sundberg, Zhihao Zhao, M. Ali Nasseri
similarity 0.65
Abstract

Age-related macular degeneration (AMD) and diabetic macular edema (DME) are leading causes of vision loss, and optical coherence tomography (OCT) is the standard modality for detecting and monitoring the subtle lesions that drive treatment decisions. Most deep-learning segmentation work for OCT is validated only in-domain, leaving generalization to clinical data collected under different acquisition protocols largely untested. This work develops and systematically ablates four lesion-segmentation pipelines -- 2D and 3D variants for AMD and DME -- reaching Dice scores of 0.76 to 0.82 with strong volumetric and surface calibration (r vol, r surf greater than or equal to 0.97 across all four pipelines) on an in-domain validation set. The ablation process establishes a full-volume, calibration-aware adoption standard that catches mechanisms an ordinary slice-level evaluation would keep, and identifies ensemble composition as the most consistent driver of improvement. To test generalization, the models are evaluated on OLIVES, an external clinical cohort with no lesion-level ground truth, using a proxy-metric framework built around biomarker AUROC, central subfield thickness (CST) correlation, and longitudinal concordance. Predictions track clinical biomarkers outside the training distribution, though less strongly than in-domain -- evidence for, not validation of, automated lesion-burden tracking as a clinical tool.

0.25